RA Capital Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,766,830
| Closed | -$82.1M | – | 98 |
|
|
2024
Q4 | $82.1M | Sell |
1,766,830
-3,242,823
| -65% | -$151M | 1.09% | 23 |
|
|
2024
Q3 | $144M | Sell |
5,009,653
-2,622,993
| -34% | -$75.5M | 1.66% | 20 |
|
|
2024
Q2 | $110M | Buy |
7,632,646
+1,314,656
| +21% | +$19M | 1.46% | 19 |
|
|
2024
Q1 | $102M | Hold |
6,317,990
| – | – | 1.29% | 24 |
|
|
2023
Q4 | $126M | Hold |
6,317,990
| – | – | 1.96% | 12 |
|
|
2023
Q3 | $103M | Hold |
6,317,990
| – | – | 2.03% | 10 |
|
|
2023
Q2 | $134M | Hold |
6,317,990
| – | – | 2.52% | 8 |
|
|
2023
Q1 | $127M | Hold |
6,317,990
| – | – | 2.87% | 7 |
|
|
2022
Q4 | $165M | Buy |
6,317,990
+267,990
| +4% | +$7M | 3.35% | 5 |
|
|
2022
Q3 | $61.8M | Buy |
6,050,000
+950,000
| +19% | +$9.71M | 1.32% | 26 |
|
|
2022
Q2 | $21.4M | Hold |
5,100,000
| – | – | 0.57% | 44 |
|
|
2022
Q1 | $25.4M | Hold |
5,100,000
| – | – | 0.56% | 50 |
|
|
2021
Q4 | $34.3M | Hold |
5,100,000
| – | – | 0.6% | 49 |
|
|
2021
Q3 | $27.9M | Hold |
5,100,000
| – | – | 0.39% | 55 |
|
|
2021
Q2 | $33.4M | Hold |
5,100,000
| – | – | 0.54% | 53 |
|
|
2021
Q1 | $42.6M | Hold |
5,100,000
| – | – | 0.64% | 44 |
|
|
2020
Q4 | $31.8M | Hold |
5,100,000
| – | – | 0.44% | 51 |
|
|
2020
Q3 | $31.8M | Buy |
+5,100,000
| New | +$31.8M | 0.58% | 42 |
|